Eli Lilly (LLY) Removed from Credit Suisse U.S Focus List
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $732.20 -1.81%
Rating Summary:
25 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
25 Buy, 8 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Credit Suisse removed Eli Lilly (NYSE: LLY) from its U.S Focus List.
The firm maintained an Outperform rating and price target of $87.
For an analyst ratings summary and ratings history on Eli Lilly click here. For more ratings news on Eli Lilly click here.
Shares of Eli Lilly closed at $73.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Senate Committee Investigates Ozempic and Wegovy Costs - NYT
- Mr. Cooper Group Inc. (COOP) PT Raised to $87 at Jefferies
- EQT Corp. (EQT) PT Lowered to $46 at Wolfe Research
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
